Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. DPH.L Share Price
  4. DPH.L Share Regulatory News
  5. Director Declaration

Pin to quick picksDPH.L Regulatory News (DPH)

DPH.L Information
  • There is currently no data for DPH

Director Declaration

29 Nov 2023 08:17

RNS Number : 0573V
Dechra Pharmaceuticals PLC
29 November 2023
 

29 November 2023

 

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

 

DIRECTOR DECLARATION

 

 

In accordance with Listing Rule 9.6.14(2) Dechra announces that Alison Platt, Non-Executive Chair of Dechra, has been appointed as a Chair of the Board and Non-Executive Director of Hargreaves Lansdown plc in early 2024.

 

For further information, please contact:

Dechra Pharmaceuticals PLC

Telephone number: +44 (0) 1606 814730

Email: corporate.enquiries@dechra.com

 

 

About Dechra

Dechra is a global veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information, please visit: www.dechra.com.

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBLBPTMTBTMBJ
12345678910
Date   Source Headline
8th Jan 20244:04 pmRNSHolding(s) in Company
8th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
8th Jan 20242:08 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
8th Jan 20241:55 pmRNSForm 8.3 - Dechra Pharmaceuticals plc Amend
8th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
8th Jan 20241:31 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
8th Jan 20241:06 pmRNSHolding(s) in Company
8th Jan 202412:55 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
8th Jan 202412:54 pmRNSHolding(s) in Company
8th Jan 202412:52 pmRNSHolding(s) in Company
8th Jan 202411:29 amRNSForm 8.3 - Dechra Pharmaceuticals plc
8th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
8th Jan 202410:38 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 20249:55 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
8th Jan 20249:30 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
8th Jan 20247:05 amRNSForm 8.3 - Dechra Pharmaceuticals plc
5th Jan 20243:30 pmRNSForm 8.3 - DPH LN
5th Jan 20243:25 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
5th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
5th Jan 20243:10 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
5th Jan 20241:50 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
5th Jan 20241:40 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
5th Jan 202411:48 amRNSForm 8.3 - Dechra Pharmaceuticals plc
5th Jan 202411:36 amRNSForm 8.3 - Dechra Pharmaceuticals plc
5th Jan 202410:46 amRNSForm 8.5 (EPT/RI)
5th Jan 202410:44 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 202410:15 amRNSForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
5th Jan 202410:08 amRNSHolding(s) in Company
5th Jan 202410:05 amRNSHolding(s) in Company
5th Jan 202410:00 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
5th Jan 20249:59 amRNSHolding(s) in Company
5th Jan 20248:53 amRNSForm 8.3 - Dechra Pharmaceuticals plc
5th Jan 20247:37 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
4th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
4th Jan 20243:30 pmRNSForm 8.3 - DPH LN
4th Jan 20243:25 pmRNSForm 8.3 - Dechra Pharmaceuticals Plc
4th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
4th Jan 20242:09 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
4th Jan 20241:55 pmRNSHolding(s) in Company
4th Jan 20241:27 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
4th Jan 20241:07 pmRNSForm 8.5 (EPT/RI)- Replacement of Dechra
4th Jan 202412:06 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
4th Jan 202411:57 amRNSForm 8.3 - Dechra Pharmaceuticals plc
4th Jan 202411:49 amRNSForm 8.3 - Dechra Pharmaceuticals plc
4th Jan 202410:57 amRNSForm 8.5 (EPT/RI)
4th Jan 202410:54 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 202410:33 amRNSForm 8.3 - Dechra Pharmaceuticals plc
4th Jan 202410:06 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
4th Jan 20249:11 amRNSHolding(s) in Company
4th Jan 20249:11 amRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
WPP
WPP
LSE
0.96%
ISF
Ish Coreftse100
LSE
0.25%
JMF
JMF.L
LSE
0.00%
CGTL.US
Creative Global Technology Holdings Ltd.
CBOE
-2.79%
TTG
Tt Electronics
LSE
0.35%
Trending
AVCT
Avacta Group
LSE
2.86%
ALRT
Defence Holdings
LSE
21.43%
PREM
Premier African Minerals
LSE
9.52%
ITM
Itm Power
LSE
-4.82%
FORG
Forgent
LSE
20.00%